BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38685449)

  • 1. Increase in Hypofractionated Radiation Therapy Among Patients with Invasive Breast Cancer or Ductal Carcinoma In Situ: Who is Left Behind?
    Booth S; Freeman JQ; Li JL; Huo D
    Pract Radiat Oncol; 2024 Apr; ():. PubMed ID: 38685449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Has Hypofractionated Whole-Breast Radiation Therapy Become the Standard of Care in the United States? An Updated Report from National Cancer Database.
    Kang MM; Hasan Y; Waller J; Saulsberry L; Huo D
    Clin Breast Cancer; 2022 Jan; 22(1):e8-e20. PubMed ID: 34257001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization trend and regimens of hypofractionated whole breast radiation therapy in the United States.
    Hasan Y; Waller J; Yao K; Chmura SJ; Huo D
    Breast Cancer Res Treat; 2017 Apr; 162(2):317-328. PubMed ID: 28120272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
    De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
    Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
    JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographic and Physician-Level Variation in the Use of Hypofractionated Radiation Therapy for Breast Cancer in the U.S.: A Cross-Classified Multilevel Analysis.
    Sun Y; Saulsberry L; Liao C; Hedeker D; Huo D
    Adv Radiat Oncol; 2024 Jun; 9(6):101487. PubMed ID: 38725638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer.
    Corrigan KL; Lei X; Ahmad N; Arzu I; Bloom E; Chun SG; Goodman C; Hoffman KE; Joyner M; Mayo L; Mitchell M; Nead KT; Perkins GH; Reed V; Reddy JP; Schlembach P; Shaitelman SF; Stauder MC; Strom EA; Tereffe W; Wiederhold L; Woodward WA; Smith BD
    Adv Radiat Oncol; 2022; 7(2):100877. PubMed ID: 35387420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing practice patterns for breast cancer radiation therapy with clinical pathways: An analysis of hypofractionation in a large, integrated cancer center network.
    Rajagopalan MS; Flickinger JC; Heron DE; Beriwal S
    Pract Radiat Oncol; 2015; 5(2):63-9. PubMed ID: 25748004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Pathways: A Catalyst for the Adoption of Hypofractionation for Early-Stage Breast Cancer.
    Chapman BV; Rajagopalan MS; Heron DE; Flickinger JC; Beriwal S
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):854-61. PubMed ID: 26530754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in utilization of hypofractionated whole breast irradiation (HF-WBI) in triple negative breast cancer (TNBC): a national cancer database (NCDB) analysis.
    Rice SR; Feigenberg SJ; Hamza M; Molitoris JK; Bentzen SM; Tkaczuk KHR; Rosenblatt PM; Bellavance EC; Nichols EM
    Breast Cancer Res Treat; 2019 Jun; 175(2):473-478. PubMed ID: 30796656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial.
    Shaitelman SF; Lei X; Thompson A; Schlembach P; Bloom ES; Arzu IY; Buchholz D; Chronowski G; Dvorak T; Grade E; Hoffman K; Perkins G; Reed VK; Shah SJ; Stauder MC; Strom EA; Tereffe W; Woodward WA; Amaya DN; Shen Y; Hortobagyi GN; Hunt KK; Buchholz TA; Smith BD
    J Clin Oncol; 2018 Oct; 36(35):JCO1800317. PubMed ID: 30379626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated Radiation Therapy for Breast Cancer: Financial Risk and Expenditures in the United States, 2008 to 2017.
    Saulsberry L; Liao C; Huo D
    Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):654-662. PubMed ID: 34637883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hypofractionated and conventionally fractionated whole-breast irradiation for early breast cancer patients: a single-institute study of 1,098 patients.
    Karasawa K; Kunogi H; Hirai T; Hojo H; Hirowatari H; Izawa H; Ito K; Sasai K; Kawashima M; Furuya T; Sugimoto S; Kurokawa C; Ozawa S; Saito M
    Breast Cancer; 2014 Jul; 21(4):402-8. PubMed ID: 22968629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation.
    Weng JK; Lei X; Schlembach P; Bloom ES; Shaitelman SF; Arzu IY; Chronowski G; Dvorak T; Grade E; Hoffman K; Perkins G; Reed VK; Shah SJ; Stauder MC; Strom EA; Tereffe W; Woodward WA; Hortobagyi GN; Hunt KK; Buchholz TA; Smith BD
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):360-370. PubMed ID: 33992718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ipsilateral breast tumor control following hypofractionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow-up.
    Yoshida-Ichikawa Y; Horimoto Y; Shikama N; Yanagisawa N; Koyanagi A; Arakawa A; Saito M; Karasawa K
    Breast Cancer; 2021 Jan; 28(1):92-98. PubMed ID: 32719997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative 3-Dimensional Photographic Assessment of Breast Cosmesis After Whole Breast Irradiation for Early Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
    Chapman BV; Lei X; Patil P; Tripathi S; Nicklaus KM; Grossberg AJ; Shaitelman SF; Thompson AM; Hunt KK; Buchholz TA; Merchant F; Markey MK; Smith BD; Reddy JP
    Adv Radiat Oncol; 2020; 5(5):824-833. PubMed ID: 33083644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.
    Deshmukh AA; Shirvani SM; Lal L; Swint JM; Cantor SB; Smith BD; Likhacheva A
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient preference study comparing hypofractionated versus conventionally fractionated whole-breast irradiation after breast-conserving surgery.
    Kawaguchi H; Tsujino K; Miki M; Matsumoto Y; Ota Y; Hirokaga K; Takao S; Soejima T; Sasaki R
    Jpn J Clin Oncol; 2019 Jun; 49(6):545-553. PubMed ID: 30796835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline.
    Smith BD; Bentzen SM; Correa CR; Hahn CA; Hardenbergh PH; Ibbott GS; McCormick B; McQueen JR; Pierce LJ; Powell SN; Recht A; Taghian AG; Vicini FA; White JR; Haffty BG
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):59-68. PubMed ID: 20638191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
    Chua BH; Link EK; Kunkler IH; Whelan TJ; Westenberg AH; Gruber G; Bryant G; Ahern V; Purohit K; Graham PH; Akra M; McArdle O; O'Brien P; Harvey JA; Kirkove C; Maduro JH; Campbell ID; Delaney GP; Martin JD; Vu TTT; Muanza TM; Neal A; Olivotto IA;
    Lancet; 2022 Aug; 400(10350):431-440. PubMed ID: 35934006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.